VulnerabilityPublished 18 Aug 2025

CVE-2025-32992: Thermo Fisher Scientific ePort · Improper Access Control

Source CVE Database V5

Not known to be exploited · CVSS 8.5 High · fixed in 3.0.1 : patch affected systems soon.

Data as of 26 Oct 2026, 13:47 UTC

CVSS 3.1 base score

8.5High

How severe the flaw is on the 0–10 CVSS scale.

EPSS: 0.2% chance of exploitation in 30 days – higher than 12% of CVEsExploit Prediction Scoring System: the likelihood attackers will use this flaw soon.
Patch: Available – fixed in 3.0.1

CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:C/C:L/I:H/A:N

Attack Vector: Network
Attack Complexity: Low
Privileges Required: Low
User Interaction: None
Scope: Changed
Confidentiality: Low
Integrity: High
Availability: None

Bold values are the worst case: easiest to exploit or largest impact.

Attack Vector: Network: The vulnerable component is bound to the network stack and the set of possible attackers extends beyond the other options listed, up to and including the entire Internet. Such a vulnerability is often termed 'remotely exploitable' and can be thought of as an attack being exploitable at the protocol level one or more network hops away (e.g., across one or more routers).
Attack Complexity: Low: Specialized access conditions or extenuating circumstances do not exist. An attacker can expect repeatable success against the vulnerable component.
Privileges Required: Low: The attacker is authorized with (i.e., requires) privileges that provide basic user capabilities that could normally affect only settings and files owned by a user. Alternatively, an attacker with Low privileges may have the ability to cause an impact only to non-sensitive resources.
User Interaction: None: The vulnerable system can be exploited without any interaction from any user.
Scope: Changed: An exploited vulnerability can affect resources beyond the security scope managed by the security authority of the vulnerable component. In this case, the vulnerable component and the impacted component are different and managed by different security authorities.
Confidentiality: Low: There is some loss of confidentiality. Access to some restricted information is obtained, but the attacker does not have control over what information is obtained, or the amount or kind of loss is limited. The information disclosure does not cause a direct, serious loss to the impacted component.
Integrity: High: There is a total loss of integrity, or a complete loss of protection. For example, the attacker is able to modify any/all files protected by the impacted component. Alternatively, only some files can be modified, but malicious modification would present a direct, serious consequence to the impacted component.
Availability: None: There is no impact to availability within the impacted component.

Definitions: FIRST CVSS v3.1 specification.

Exploitation evidence

Disclosed: evidence found.
CVE published 18 Aug 2025
Detectable: no evidence on record.
No public nuclei template indexed
Weaponised: no evidence on record.
No public exploit code indexed in Metasploit or Exploit-DB
Exploited in the wildExploited: no evidence on record.
Not in CISA KEV and no source reports exploitation
Observed by OffSeq MirageSeen by Mirage: no evidence on record.
No attack traffic recorded by OffSeq Mirage sensors

A missing step is not evidence of safety. Sources: cve.org (opens in a new tab), the Metasploit, Exploit-DB and nuclei-templates index as of 26 Oct 2026.

Disclosed: The CVE record is public on cve.org. Its publication is t = 0.
Detectable: A public nuclei template can find exposed instances, for defenders and attackers alike.
Weaponised: Public exploit code exists in Metasploit or Exploit-DB, or CISA SSVC or the CVSS exploit maturity reports a public proof of concept.
Exploited in the wild: CISA KEV lists it, CISA SSVC rates exploitation active, or a source reports attacks.
Observed by OffSeq Mirage: OffSeq Mirage honeypot sensors recorded attack traffic for this CVE, or found exposed hosts without attack traffic.

Moments are spaced evenly, not to scale; a dashed line marks a gap of six months or more. Deltas count from t = 0. Sources that give only a date (CISA KEV, Exploit-DB, or a time of exactly 00:00Z) read “same day” rather than hours. Metasploit modules carry the flaw’s disclosure date, not their release date, and nuclei templates carry no date, so both appear above but not on the timeline.

What to do

AI-suggested

In the absence of an official patch, European organizations should immediately conduct a thorough access control audit of their ePort deployments. This includes reviewing user roles and permissions to ensure the principle of least privilege is enforced, disabling or restricting access for non-essential users, and monitoring access logs for unusual activity. Network segmentation should be implemented to isolate the ePort system from less trusted networks and limit exposure. Employing multi-factor authentication (MFA) where possible can add an additional layer of security. Organizations should also engage with Thermo Fisher Scientific for updates on patch availability and apply any vendor-recommended mitigations promptly. Implementing intrusion detection and prevention systems (IDPS) focused on detecting anomalous access patterns to the ePort system can help identify exploitation attempts early. Finally, organizations should prepare incident response plans specific to this vulnerability, including data backup and recovery procedures to mitigate potential data integrity issues.

Description

Thermo Fisher Scientific ePort through 3.0.0 has Incorrect Access Control.

Impact

For European organizations, especially those in the pharmaceutical, biotechnology, academic research, and healthcare sectors that rely on Thermo Fisher Scientific's ePort software, this vulnerability poses a significant risk. Unauthorized access could lead to exposure or manipulation of sensitive research data, intellectual property theft, disruption of laboratory workflows, and potential regulatory non-compliance with data protection laws such as GDPR. The integrity of scientific results could be compromised, affecting downstream research and product development. Additionally, if the ePort system interfaces with other critical infrastructure or laboratory instruments, exploitation could have cascading effects on operational availability and safety. The reputational damage and financial costs associated with data breaches or operational disruptions in these sectors can be substantial. Given the strategic importance of scientific research and healthcare in Europe, the vulnerability could also attract targeted attacks from threat actors seeking to gain competitive or geopolitical advantages.

CWE-284Improper Access Control (opens in a new tab)
Pillar weaknessCWE Top 25 (2025): #19OWASP Top 10 A01:2025: Broken Access Control (opens in a new tab)
The product does not restrict or incorrectly restricts access to a resource from an unauthorized actor.
MITRE discourages mapping vulnerabilities to this broad entry; the root cause is usually a more specific weakness.
Architecture and Design · Operation
Very carefully manage the setting, management, and handling of privileges. Explicitly manage trust zones in the software.
Architecture and Design · Separation of Privilege
Compartmentalize the system to have "safe" areas where trust boundaries can be unambiguously drawn. Do not allow sensitive data to go outside of the trust boundary and always be careful when interfacing with a compartment outside of the safe area.
OWASP Cheat Sheets
Docker Security (opens in a new tab)
Third Party Javascript Management (opens in a new tab)
Virtual Patching (opens in a new tab)
Authorization (opens in a new tab)
OWASP ASVS 4.0.3
V1.4.4 (opens in a new tab)
V1.4.5 (opens in a new tab)
V1.10.1 (opens in a new tab)
Attack patterns
Embedding Scripts within Scripts (opens in a new tab)
Modification of Windows Service Configuration (opens in a new tab)
Malicious Root Certificate (opens in a new tab)
Intent Spoof (opens in a new tab)
WebView Exposure (opens in a new tab)
From MITRE CWE, MITRE CAPEC and OWASP (Top 10, OpenCRE).

References

Community reviews

Loading reviews…

Exploitation evidence

What to do

Description

AI analysisMachine-generated, updated 18 Aug 2025, 20:17 UTC

WeaknessesCWE-284

Technical details

References

Community reviews

Related threats